“Stop dropping coverage for breast cancer patients” warns U.S to Well Point
In a letter to Angela Braly, Well Point’s Chief Executive, Kathleen Sebelius has called on health insurer Well Point to stop dropping coverage for patients recently diagnosed with breast cancer, calling the practice “deplorable’. It may be noted that Reuters reported on Thursday that Well Point was using a computer algorithm that automatically targeted patients recently diagnosed with breast cancer, among the other conditions.
Sebelius wrote in her letter, “Well Point should not wait to end the unconscionable practice of deliberately working to deny health insurance coverage to women diagnosed with breast cancer. I urge you to immediately cease these practices and abandon your efforts to rescind health insurance coverage from patients who need it most.” Ceo Braly responded to Sebelius in a letter on Friday saying, “The Reuters report was inaccurate and grossly misrepresented the insurance company's efforts to help patients detect and treat cancer. Breast cancer is a devastating illness and should not be politicized”,.
The news had Well Point shares fall 0.7 percent on Friday to $57.98, compared with 0.9 percent rise for the Morgan Stanley Healthcare Payer index. Cameron Lewis, the Division Spokeswoman, said that the assessment is due to be completed on time in the next week and will be sent to Well Point for review. Lewis told the Independent, “We’re looking at a period of up to 60 days after we file the first review. It could be less than that but until the report goes back and forth we’re required by law to keep the findings confidential.”
New Zealand News
- First deliveries of all-electric Porsche in Australia to take place this weekend
- Crown Resorts suffers record six-month loss due to COVID-19 closures
- Australia’s Crown Resorts 'not suitable' for Sydney gaming license: Inquiry Commission
- What Does Phasing Out Cheques Tell Us About Finance in New Zealand?
- South Korean casino operator GKL closes third casino amid soaring cases of COVID-19